A PHASE III MULTICENTER, RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY OF FENEBRUTINIB COMPARED WITH TERIFLUNOMIDE IN ADULT PATIENTS WITH RELAPSING MULTIPLE SCLEROSIS
![](https://researchstudies.cuanschutz.edu/Content/images/study-category-images/brain-nervous.jpg)
Details
Age
Adult
Locations
Brain Imaging Center (BIC)
University of Colorado Hospital
Principal Investigator
![Photograph of Enrique Alvarez](https://som.ucdenver.edu/FIMS/Content/faculty/21380/CU-Doctors-21380.jpg)
Enrique Alvarez
Study ID
Protocol Number: 20-2036
More information available at ClinicalTrials.gov: NCT04586010
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers